Schedule 13G ownership disclosure

ASPIRE BIOPHARMA HLDGS INC

Common Stock · CUSIP: 738920107

Event date: 2025-04-04

Filing-level shares
4,183,375.00
Percent of class
8.55%
  • Lance Friedman

    Shares: 4,183,375.00 · Class: 8.55%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-003869
Form type
SCHEDULE 13G/A
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
Apr 11, 2025
Reporting period
Apr 04, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub